• Home
  • About IBT
    • Vision and Mission
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Pipeline
    • IBP-9414
    • IBP-1016
    • IBP-1118
    • IBP-1122
  • Families
  • Healthcare Professionals
  • Investors & Media
    • Shares
    • Presentations
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • News
    • Investors & Media Contact
    • Subscribe
  • Contact Us
  • Career
IBT Logo IBT Logo
  • En
  • Sv
  • Home
  • About IBT
    • Vision and Mission
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Pipeline
    • IBP-9414
    • IBP-1016
    • IBP-1118
    • IBP-1122
  • Families
  • Healthcare Professionals
  • Investors & Media
    • Shares
    • Presentations
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • News
    • Investors & Media Contact
    • Subscribe
  • Contact Us
  • Career

Press releases


Prospectus relating to Infant Bacterial Therapeutics’ rights issue published

 

To access the press release, please read the following disclaimer here.

 

January 10, 2018

Latest press releases

Notice of Extraordinary General Meeting of Infant Bacterial Therapeutics
IBT resolves on a rights issue
Infant Bacterial Therapeutics AB (publ), Interim report January 1-March 31, 2023
Annual General Meeting of Infant Bacterial Therapeutics
Notice of Annual General Meeting of Infant Bacterial Therapeutics
This site uses cookies – small text-based files that are placed on your device to help us provide a better user experience. Find out more.
Contact | info@ibtherapeutics.com
© Copyright Infant Bacterial Therapeutics AB 2023
Cookie Policy Privacy Policy Terms of Use